Skip to content

Clinical trials

Terminated Lymphoma, Follicular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Status: Terminated Country / region: United States Clear all

201 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20021
20032
200411
200511
20069
200710
200811
20097
201015
20113
20124
201311
20148
201510
20169
20176
201812
20197
20205
202110
20226
20236
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated201

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
Masonic Cancer Center, University of Minnesota8
Gilead Sciences6
OHSU Knight Cancer Institute6
City of Hope Medical Center5
Fred Hutchinson Cancer Center5
University of Washington5
Case Comprehensive Cancer Center4
Columbia University4
MEI Pharma, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular201
Lymphoma, Large B-Cell, Diffuse111
Leukemia, Lymphocytic, Chronic, B-Cell110
Lymphoma, Mantle-Cell104
Lymphoma, B-Cell, Marginal Zone103
Lymphoma, Non-Hodgkin102
Lymphoma71
Burkitt Lymphoma68
Precursor Cell Lymphoblastic Leukemia-Lymphoma67
Lymphoma, Large-Cell, Immunoblastic59

Trials

Showing 1 to 25 of 201. Each trial links to its page on Pharma Observatory.

101 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.